CARIBOU BIOSCIENCES INC. - COMMON STOCK
2.0200
22-十一月-24 16:44:58
15 分钟延时
股票
+0.0400
+2.02%
今日范围
1.9315 - 2.0500
ISIN
N/A
来源
NASDAQ
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
20 11月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
06 11月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
25 9月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
03 9月 2024 08:01:11 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
26 8月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
12 8月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update
06 8月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences Announces Appointment of Terri Laufer, MD, to its Scientific Advisory Board
09 7月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
30 5月 2024 16:01:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
07 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
01 5月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
24 4月 2024 10:00:00 条件 Nasdaq GlobeNewswire
-
15 4月 2024 09:00:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
04 4月 2024 16:00:00 条件 Nasdaq GlobeNewswire
-
11 3月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
05 3月 2024 16:30:00 条件 Nasdaq GlobeNewswire
-
Caribou Biosciences to Participate in Upcoming Investor Conferences
15 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
07 1月 2024 11:00:00 条件 Nasdaq GlobeNewswire
-
12 12月 2023 16:02:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >